Back to top
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Image: Bigstock
DTE Energy (DTE) Q1 Earnings Top Estimates, Keeps '18 View
Detroit, MI-based DTE Energy Company (DTE - Free Report) is a holding company with subsidiaries engaged in regulated and unregulated energy businesses. The company’s largest regulated subsidiaries comprise DTE Electric Company and DTE Gas Company.
Surprise History
Coming to the earnings surprise, DTE Energy has surpassed the Zacks Consensus Estimate in three of the last four quarters, resulting in a positive average surprise of 5.32%.
DTE Energy Company Price and EPS Surprise
DTE Energy Company Price and EPS Surprise | DTE Energy Company Quote
Zacks Rank: Currently, DTE Energy has a Zacks Rank #3 (Hold) but that could change following its first quarter 2018 earnings report which has just released. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
We have highlighted some of the key details from the just-released announcement below:
Earnings: DTE Energy’s adjusted earnings per share came in at $1.91, which surpassed the Zacks Consensus Estimate of $1.89 by 1.05%
Key Stats: The company reaffirms its 2018 operating earnings per share guidance in the range of $5.57-$5.99.
Check back later for our full write up on this DTE Energy Company earnings report later!
Investor Alert: Breakthroughs Pending
A medical advance is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating substantial revenue, and even more wondrous products are in the pipeline.
Cures for a variety of deadly diseases are in sight, and so are big potential profits for early investors. Zacks names 5 stocks to buy now.
Click here to see them >>